arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

BioLineRx Ltd.

BLRX Health Care Biotechnology: Pharmaceutical Preparations
$2.06
▼ -6.7% Today
as of Oct 22, 16:46 ET
Last 30 days -15.23% Sep 14 → Oct 22
$1.93 $2.11 $2.29 $2.47 $2.65 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$2.07
High
$2.17
Low
$1.99
Volume
$4,895
Avg Vol
$27,141
Mkt Cap
$12M
P/E (TTM)
—
Beta
—
52w High
$3.95
52w Low
$1.95
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 7 items

Oct 8 · 11:00 PR PR Newswire
BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day
Sep 10 · 11:00 PR PR Newswire
BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
Sep 1 · 12:05 Zacks Small Cap Research
BLRX: New GLIX1 Data Touts Synergies
▸ Show all 7 press releases & news Free account →

BLRX earnings at a glance

The options market is pricing a move of about ±230.9% after the report, a range of roughly -$2.70 to $6.82 from today's $2.06. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±3.6% on average; after the most recent report on May 27, 2026 it moved +6.6%. That means options currently expect more movement than BLRX has typically delivered. BLRX beat the consensus EPS estimate in 1 of its last 2 reported quarters. Implied volatility is currently 20%. The share price of $2.06 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.95
$3.95
6% of range
Avg surprise (last 2)
+39.9%
Avg reaction (last 2)
+3.6%
100% positive
Latest IV / EM
1955%
EM ±230.9% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.84$-0.28$0.28$0.83$1.39 Actual $1.39Est $-0.84Actual $1.00Est $-0.35Actual $-0.36 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 27, 2026Mar/2026 $-0.36 — — -125.9% +6.6% earnings
Thu Aug 14, 2025Jun/2025 $1.00 $-0.35 -185.7% — — earnings
Tue May 27, 2025Mar/2025 $1.39 $-0.84 +265.5% — +0.5% earnings

Implied volatility — last 90 days

135%766%1398%2029%2661% Jun 15 — IV 2173% · EM ±157.2%Jun 16 — IV 2661% · EM ±157.2%Jul 13 — IV 135% · EM ±11.3%Jul 14 — IV 169% · EM ±12.2%Jul 29 — IV 883% · EM ±176.8%Jul 30 — IV 939% · EM ±184.0%Aug 24 — IV 845% · EM ±176.5%Aug 25 — IV 866% · EM ±177.1%Aug 28 — IV 1041% · EM ±199.2%Aug 31 — IV 1050% · EM ±186.1%Sep 23 — IV 1024% · EM ±205.1%Sep 24 — IV 1039% · EM ±203.6%Sep 25 — IV 1039% · EM ±198.8%Sep 28 — IV 1196% · EM ±211.9%Sep 29 — IV 1267% · EM ±218.2%Sep 30 — IV 1312% · EM ±219.1%Oct 01 — IV 1372% · EM ±222.0%Oct 02 — IV 1421% · EM ±222.0%Oct 05 — IV 1569% · EM ±217.3%Oct 06 — IV 1666% · EM ±220.1%Oct 07 — IV 144% · EM ±18.1%Oct 08 — IV 1955% · EM ±230.9%

Sector peers

ASBP
Aspire-Lakewood Holdings, Inc.
$11M $8.90+2.1%
CALC
CalciMedica, Inc.
$11M $1.15+8.0%
KPRX
Kiora Pharmaceuticals, Inc.
$11M $2.32-0.4%
MBRX
Moleculin Biotech, Inc.
$10M $5.89-6.7%
LEXX
Lexaria Bioscience Corp.
$14M $2.99+12.8%
KPTI
Karyopharm Therapeutics Inc.
$15M $0.55+52.1%

BLRX earnings FAQ

What is BLRX's expected move for earnings?

Options currently price a move of about ±230.9%, or $4.76 per share either way from $2.06.

How does BLRX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.6%, up 2 times and down 0 times.

What is BLRX's implied volatility?

BLRX's at-the-money implied volatility is about 20% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in